WallStreetZenWallStreetZen

NASDAQ: PDSB
Pds Biotechnology Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

PDSB earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$42.9M
Current Profit Margin
0%

PDSB Return on Equity

Current Company
-138.4%
Current Industry
-63.5%
Current Market
188%
PDSB's Return on Equity (-138.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when PDSB announces earnings.

PDSB Return on Assets

Current Company
-69%
Current Industry
2.9%
PDSB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

PDSB Return on Capital Employed

Current Company
-94.07%
Current Industry
19.5%
PDSB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PDSB vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
PDSB$0.00-$42.87M-$42.94MN/AN/A
AMLX$380.79M$55.39M$49.27M+304.24%N/A
KPTI$146.03M-$118.42M-$143.10M+36.93%N/A
CTXR$0.00-$37.41M-$39.33MN/AN/A
COYA$6.00M-$7.24M-$7.99MN/AN/A
View Top Biotech Stocks

PDSB earnings dates

Next earnings date
Jun 24, 2024

Pds Biotechnology Earnings & Revenue FAQ

What were PDSB's earnings last quarter?

On Invalid Date, Pds Biotechnology (NASDAQ: PDSB) reported Q4 2023 earnings per share (EPS) of -$0.35, up 47.76% year over year. Total Pds Biotechnology earnings for the quarter were -$10.90 million. In the same quarter last year, Pds Biotechnology's earnings per share (EPS) was -$0.67.

If you're new to stock investing, here's how to buy Pds Biotechnology stock.

What was PDSB's earnings growth in the past year?

As of Q2 2024, Pds Biotechnology's earnings has grown year over year. Pds Biotechnology's earnings in the past year totalled -$42.94 million.

What is PDSB's earnings date?

Pds Biotechnology's earnings date is Invalid Date. Add PDSB to your watchlist to be reminded of PDSB's next earnings announcement.

What was PDSB's revenue last quarter?

On Invalid Date, Pds Biotechnology (NASDAQ: PDSB) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Pds Biotechnology's revenue was $0.00.

What was PDSB's revenue growth in the past year?

As of Q2 2024, Pds Biotechnology's revenue has grown null year over year. Pds Biotechnology's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.